Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 218

    1.

    Sibutramine use associated with reversible hepatotoxicity.

    Chounta A, Tsiodras S, Zouridakis S, Doumas M, Giamarellou H.

    Ann Intern Med. 2005 Nov 15;143(10):763-4. No abstract available. PMID: 16287809 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Psychosis with sibutramine.

    Rosenbohm A, Bux CJ, Connemann BJ.

    J Clin Psychopharmacol. 2007 Jun;27(3):315-7. No abstract available. PMID: 17502790 [PubMed - indexed for MEDLINE]Related articles

    3.

    [Study of heart valve function on obese patients treated with sibutramine]

    Pereira JL, López-Pardo F, Parejo J, Astorga R, Rodríguez-Puras MJ, García-Luna PP.

    Med Clin (Barc). 2002 Jan 26;118(2):57-9. Spanish. PMID: 11809145 [PubMed - indexed for MEDLINE]Related articles

    4.

    Obesity drug sibutramine (Meridia): hypertension and cardiac arrhythmias.

    Wooltorton E.

    CMAJ. 2002 May 14;166(10):1307-8. No abstract available. PMID: 12041851 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    [Abuse potential of sibutramine]

    Saiz Ruiz J, Saiz González D, Antón Fructuoso P.

    Med Clin (Barc). 2003 May 3;120(16):639. Spanish. No abstract available. PMID: 12732133 [PubMed - indexed for MEDLINE]Related articles

    6.

    Sibutramine: an Australian analysis of reported adverse effects.

    [No authors listed]

    Prescrire Int. 2007 Jun;16(89):114. No abstract available. PMID: 17590911 [PubMed - indexed for MEDLINE]Related articles

    7.

    Sibutramine-associated psychotic episode.

    Taflinski T, Chojnacka J.

    Am J Psychiatry. 2000 Dec;157(12):2057-8. No abstract available. PMID: 11097984 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    [Observational study. Sibutramine in general practice]

    [No authors listed]

    MMW Fortschr Med. 2001 Apr 12;143(15):43. German. No abstract available. PMID: 11349321 [PubMed - indexed for MEDLINE]Related articles

    9.

    Hypomanic episode secondary to sibutramine in a patient with type-I bipolar disorder.

    Rocha FF, Bamberg TO, Pinto FC, Gomes LM, Silveira S.

    Rev Bras Psiquiatr. 2008 Dec;30(4):400-1. No abstract available. PMID: 19142420 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Sibutramine for obesity.

    [No authors listed]

    Med Lett Drugs Ther. 1998 Mar 13;40(1022):32. No abstract available. PMID: 9529518 [PubMed - indexed for MEDLINE]Related articles

    11.

    Cardiovascular effects of sibutramine.

    Pisarik P.

    Pediatrics. 2007 Oct;120(4):930-1; author reply 931-2. No abstract available. PMID: 17908786 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Sibutramine-associated adverse effects: a practical guide for its safe use.

    Florentin M, Liberopoulos EN, Elisaf MS.

    Obes Rev. 2008 Jul;9(4):378-87. Epub 2007 Nov 23. Review.PMID: 18034790 [PubMed - indexed for MEDLINE]Related articles

    13.

    Sibutramine: balancing weight loss benefit and possible cardiovascular risk.

    de Simone G, D'Addeo G.

    Nutr Metab Cardiovasc Dis. 2008 Jun;18(5):337-41. Epub 2008 May 27. No abstract available. PMID: 18502626 [PubMed - indexed for MEDLINE]Related articles

    14.

    The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessment.

    O'Meara S, Riemsma R, Shirran L, Mather L, ter Riet G.

    Health Technol Assess. 2002;6(6):1-97. Review. No abstract available. PMID: 12000688 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Serotonin syndrome risk with antiobesity drug.

    Trakas K, Shear NH.

    Can J Clin Pharmacol. 2000 Winter;7(4):216. No abstract available. PMID: 11221780 [PubMed - indexed for MEDLINE]Related articles

    16.

    Weighing in on Meridia.

    [No authors listed]

    Harv Womens Health Watch. 1998 Feb;5(6):7. No abstract available. PMID: 9600049 [PubMed - indexed for MEDLINE]Related articles

    17.

    The safety profiles of orlistat and sibutramine: results of prescription-event monitoring studies in England.

    Perrio MJ, Wilton LV, Shakir SA.

    Obesity (Silver Spring). 2007 Nov;15(11):2712-22.PMID: 18070762 [PubMed - indexed for MEDLINE]Related articles

    18.

    Caution for new diet drug.

    [No authors listed]

    Health News. 1998 Mar 31;4(4):5. No abstract available. PMID: 9553607 [PubMed - indexed for MEDLINE]Related articles

    19.

    Sibutramine and panic attacks.

    Binkley K, Knowles SR.

    Am J Psychiatry. 2002 Oct;159(10):1793-4. No abstract available. PMID: 12359693 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Sibutramine (Meridia)--dental considerations for a new weight control drug.

    Wynn RL.

    Gen Dent. 1998 Jul-Aug;46(4):332-5. Review. No abstract available. PMID: 9758977 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data